CClinicalTrials.gg
WithdrawnNCT02590380Updated Oct 21, 2021

Comparing Pedicle Screw Systems for the Treatment of Adolescent Paediatric Spine Deformity

An interventional study of MESA Rail Deformity System and DePuy Synthes USS II System in Adolescent Idiopathic Scoliosis, sponsored by K2M, Inc.. Withdrawn at 1 site in United Kingdom. Open to participants aged 11 Years to 21 Years. Per ClinicalTrials.gov, last updated 2021-10-21.

Sponsored by K2M, Inc. · Not applicable, Interventional, and Treatment

Why this study was withdrawn
Study was not started
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
11 Years to 21 Years
Sex
All
01

Study summary

Evaluation of the efficacy of the K2M MESA Rail™ Deformity System at improving coronal and sagittal correction of the adolescent idiopathic spine deformity in comparison to the side loading DePuy Synthes USS II pedicle screw system.

Read the detailed description

Evaluation of the efficacy of the K2M MESA Rail™ Deformity System at improving coronal and sagittal correction of the adolescent idiopathic spine deformity in comparison to the side loading DePuy Synthes USS II pedicle screw system. This is a single-center, single-surgeon randomized controlled trial with follow-up evaluations of patients conducted at initial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure. Adverse events will be monitored continuously.

02

Conditions studied

  • Adolescent Idiopathic Scoliosis

Keywords

  • Adolescent
  • paediatric
  • pediatric
  • scoliosis
  • spine deformity
03

In context

Scoliosis

594 studies on the registry are indexed under Scoliosis; 139 are open to participants now.

Browse Scoliosis studies →

Lead sponsor

K2M, Inc. is the lead sponsor of 7 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 21 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Diagnosis of Adolescent Idiopathic Scoliosis (AIS) with no associated syndrome requiring surgical treatment for selective thoracic/lumbar fusion with a minimum of five (5) instrumented vertebrae between T1-S1 as confirmed by patient history and radiographic studies. AIS cases must be classified as a Lenke type 1 or type 2 curve. No cervical vertebrae are to be incorporated into the construct.
  2. Willingness and ability to comply with the requirements of the protocol including follow-up requirements.
  3. Willing and able to sign a study specific informed consent form or, in the case of a patient who is a minor, provide assent and the minor patient's parent/legal guardian provides written consent to participate.
  4. Age range of ≥ 11 years old and ≤ 21 years old at time of surgery.

Exclusion criteria

Exclusion Criteria:

  1. Previous anterior or posterior spine surgery at the index levels.
  2. Previous posterior spine surgery (e.g., posterior element decompression) that destabilizes the cervical/thoracic/lumbar spine.
  3. Active systemic infection or infection at the operative site.
  4. Any sign of any spinal dysrhaphism (any cord abnormality).
  5. Co-morbid medical conditions of the spine or upper/lower extremities that may affect the thoracic or lumbar spine neurological and/or pain assessment.
  6. Metabolic bone disease such as osteoporosis that contradicts spinal surgery.
  7. History of an osteoporotic fracture.
  8. History of an endocrine or metabolic disorder (e.g., Paget's disease) known to affect bone and mineral metabolism.
  9. Taking medications that may interfere with bony/soft tissue healing including chronic oral steroid use.
  10. Known allergy to titanium or cobalt chrome.
  11. Rheumatoid arthritis or other autoimmune disease or a systemic disorder such as HIV, active hepatitis B or C or fibromyalgia.
  12. Insulin-dependent type 1 or type 2 diabetes.
  13. Medical condition (e.g., unstable cardiac disease, cancer) that may result in patient death or have an effect on outcomes prior to study completion.
  14. Pregnant, or intend to become pregnant, during the course of the study.
  15. Severe obesity (Body Mass Index > 40).
  16. Physical or mental condition (e.g., psychiatric disorder, senile dementia, Alzheimer's disease, alcohol or drug addiction) that would interfere with patient self-assessment of function, pain or quality of life.
  17. Incarcerated at the time of study enrollment.
  18. Current participation in an investigational study that may impact study outcomes.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Active comparator
    treatment group (MESA)

    Patients randomized to the treatment group will receive surgery with the MESA Rail Deformity System.

    Device: MESA Rail Deformity System

  • Active comparator
    control group (USS II)

    Patients randomized to the control group will receive surgery with the DePuy Synthes USS II System.

    Device: DePuy Synthes USS II System

Interventions

  • DeviceMESA Rail Deformity System

    The spinal deformity will be correction via a standard of care procedure performed by the principal investigator. The correction will be fixated with the MESA Rail Deformity System.

    Also known as: MESA Rail, K2M MESA Rail, MESA, K2M MESA

  • DeviceDePuy Synthes USS II System

    The spinal deformity will be correction via a standard of care procedure performed by the principal investigator. The correction will be fixated with the DePuy Synthes USS II system.

    Also known as: DePuy, DePuy Synthes, Synthes, USS II, Universal Stainless

06

What researchers measure

Primary outcomes

  1. Correction and Maintenance of Spinal Deformity (coronal)

    Radiographic analysis of the spinal deformity in the coronal plane at the indicated time periods will be compared to the pre-operative measurements (OVERALL CHANGE from baseline at each timepoint). Later post-operative measurements will be compared to the initial correction values to establish maintenance of surgical correction over time.

    Time frame: Change from pre-operative to 3 months, 12 months and 24 months post-procedure

  2. Correction and Maintenance of Spinal Deformity (sagittal)

    Radiographic analysis of the spinal deformity in the sagittal plane at the indicated time periods will be compared to the pre-operative measurements (OVERALL CHANGE from baseline at each timepoint). Later post-operative measurements will be compared to the initial correction values to establish maintenance of surgical correction over time.

    Time frame: Change from pre-operative to 3 months, 12 months and 24 months post-procedure

Secondary outcomes

  1. Back and Leg Pain 10cm Visual Analog Scale (VAS)

    The severity of back and leg pain will be evaluated in all study subjects using a 10-cm visual analog scale (VAS). The study will employ a 15% improvement for success. OVERALL CHANGE from baseline will be assessed at each timepoint.

    Time frame: Initial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure.

  2. SRS-22

    Scoliosis and its treatment have a great impact on the quality of life of the affected patients. The Revised Scoliosis Research Society-22 (SRS-22r) is a specific questionnaire for spine conditions. It is applied to patients with idiopathic scoliosis, whose conditions and treatments have a great impact on their quality of life. The SRS-22r was created and revised with the purpose of evaluating this impact from the patient's point of view. The reviewed version contains 22 questions distributed into five domains: function/activity (FA), pain (P), self-image/appearance (SA), mental health (MH) and satisfaction with treatment (ST). The scores vary from 1 to 5, in which 5 is the best health quality of life of patients. OVERALL CHANGE from baseline will be assessed at each timepoint.

    Time frame: Initial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure.

  3. Estimated Blood Volume Loss/Salvage Return

    The amount of blood loss over the entire length of the surgery as well as salvage return volumes will be captured intraoperatively.

    Time frame: Operative Data - to be collected immediately after case is completed. Estimated blood loss will be noted by the surgical/anesthesia team and this value can then be immediately collected.

  4. Length of Hospital Stay

    The length of hospital stay from the date of admission to the date of discharge will be calculated.

    Time frame: At discharge (up to one week post surgery) - Once the subject has been released from the hospital, the length of hospital stay can be calculated using the intake and discharge dates.

  5. Return to Work/School

    The ability to and the time it takes for the subject to be cleared to return to work/school from the date of surgery will be documented. Once the subject has returned to the "baseline" status this question will not be asked.

    Time frame: Initial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure.

  6. Return to Sport/Physical Activity

    The ability to return to sport as performed by the individual patient pre operatively. Time to walking unaided, running, swimming, trampoline, contact sport, normal social interactions with peer group. Once the subject has returned to the "baseline" status this question will not be asked.

    Time frame: Initial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure.

  7. Use of Analgesia Post-Surgery

    The types and dosages of any analgesia taken by the patient post-surgery will be documented. Overall change from baseline (pre-operative medications) will be analyzed at each interval - anticipation is that use of analgesia decreases and/or ends after surgery.

    Time frame: Initial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure.

07

Study locations

1 site
  • University Hospital Southampton
    Southampton, S)16 6YD, United Kingdom
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 21, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02590380
Lead sponsor
K2M, Inc.
Responsible party
Sponsor
First posted
Oct 29, 2015
Start date
Sep 2022 (estimated)
Primary completion
Sep 2028 (estimated)
Completion
Sep 2030 (estimated)
Last update
Oct 21, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion